| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jul 14, 2025 | Jul 16, 2025 | INCYTE CORP | President | Sell | 92.5 | +13,630 | 6.16% | ✗ | $268.9K |
| Jul 15, 2024 | Jul 17, 2024 | INCYTE CORP | President | Sell | 86.3 | +19,102 | 9.45% | ✗ | $48.1K |
| Nov 19, 2019 | Nov 21, 2019 | CRISPR Therapeutics AG | Director | Sell | 7.5 | -7,500 | -100.00% | ✓ | $465K |
| Nov 12, 2019 | Nov 13, 2019 | CRISPR Therapeutics AG | Director | Sell | 7.5 | -7,500 | -100.00% | ✓ | $412.5K |
| Oct 30, 2019 | Nov 1, 2019 | CRISPR Therapeutics AG | Director | Sell | 7.5 | -7,500 | -100.00% | ✓ | $390K |
| Jul 3, 2018 | Jul 5, 2018 | CRISPR Therapeutics AG | Director | Sell | 7.5 | -7,500 | -100.00% | ✓ | $465K |